Clinical and research resources for professionals.

A structured reference for clinicians, researchers, and educators working in behavioral addiction. Grounded in current diagnostic criteria, neurobiological evidence, and treatment literature.

Clinical overview of behavioral addiction

Behavioral addiction refers to patterns of recurrent engagement in specific activities that lead to functional impairment or clinically significant distress, despite attempts to reduce or discontinue the behavior.

Unlike substance-use disorders, diagnostic criteria do not require ingestion of a psychoactive substance.

Core clinical features commonly described in the literature include repeated difficulty resisting urges, escalating engagement over time, increasing preoccupation, and persistence despite adverse occupational, social, or psychological consequences.

Conceptually aligned with ICD-11 (WHO, 2019) and DSM-5-TR research criteria.

The neuropsychological profile closely parallels that observed in substance-use disorders, with convergent evidence from fMRI, PET imaging, and longitudinal cohort studies supporting shared reward-circuitry dysregulation as a unifying mechanism.

Nosological Classification Status

Formally
Recognized

Gambling Disorder

Included in both ICD-11 and DSM-5-TR as a standalone behavioral addiction category with full diagnostic criteria.

Emerging
Evidence

Gaming Disorder

ICD-11 includes Gaming Disorder as a formal diagnosis. DSM-5-TR retains Internet Gaming Disorder in Section III as a condition for further study.

Under
Study

Compulsive buying, problematic social media use, compulsive sexual behavior

A growing body of literature examines shared neurobiological and behavioral mechanisms; formal diagnostic criteria remain under active study.

Clinical Assessment Considerations

Effective assessment extends beyond confirming diagnostic criteria and should address symptom pattern, functional impairment, comorbidity, and risk profile.

1

Symptom Pattern & Severity

Frequency, duration, loss of control, escalation, and impairment.

2

Differential Diagnosis

Bipolar spectrum disorders, OCD-spectrum disorders, ADHD, substance-use comorbidity.

3

Comorbidity & Risk

Mood disorders, anxiety, trauma, personality structure, suicidality, financial crisis.

4

Functional Analysis

Antecedents, emotional triggers, reinforcement patterns, consequences.

Key indicators for clinical evaluation

Validated screening instruments remain limited for several behavioral addiction categories. These indicators, drawn from convergent research, can support structured clinical assessment while formal psychometric tools are still in development.

Structured Screening Instruments

PGSI, SOGS (gambling); IGDS9-SF (gaming); emerging scales for other behaviors.

Frequency & Intensity Metrics

Escalation, failed reduction attempts, duration patterns.

Functional Impairment Mapping

Occupational, financial, relational, academic impact.

Comorbidity Screening

Depression, anxiety, trauma, ADHD, substance use.

Risk & Safety Assessment

Suicidality, financial destabilization, crisis indicators.

Functional Behavioral Analysis

Identifying reinforcement cycles and maintaining mechanisms.

Neurobiological Basis

Behavioral addictions are associated with dysregulation across neural systems involved in reward processing, executive control, and stress responsivity.

Reward System Sensitization – cue-triggered salience and relapse vulnerability.

Executive Control & Inhibitory Regulation – context-dependent impulsivity and planning deficits.

Stress Reactivity & Habit Learning – automatic behavioral responses to affective states.

Treatment Frameworks & Modalities

The evidence base for behavioral addiction treatment draws heavily from substance-use disorder literature and is expanding rapidly. Tags indicate current strength of evidence within behavioral addiction specifically.

1

Cognitive-Behavioral Interventions

Cognitive restructuring, stimulus control, relapse prevention.

2

Motivational Enhancement Strategies

Stage-matched engagement and ambivalence resolution.

3

Behavioral Regulation & Relapse Prevention

Contingency planning and structured safeguards.

4

Trauma-Informed & Emotion Regulation Approaches

Distress tolerance and trauma integration.

5

Family & Systems-Based Interventions

Addressing relational reinforcement cycles.

6

Pharmacologic Considerations

Adjunctive treatment of comorbid psychiatric conditions.

Resources for your practice

Curated materials for clinicians, researchers, and educators — designed to support clinical decision-making and continuing education.

Research & Evidence Summaries

Curated clinically relevant literature.

Clinical Decision Support

Structured assessment and treatment-planning frameworks.

Patient Education Resources

Plain-language materials to support clinical engagement.